[go: up one dir, main page]

GT199800161A - Derivado de indol util en terapia. - Google Patents

Derivado de indol util en terapia.

Info

Publication number
GT199800161A
GT199800161A GT199800161A GT199800161A GT199800161A GT 199800161 A GT199800161 A GT 199800161A GT 199800161 A GT199800161 A GT 199800161A GT 199800161 A GT199800161 A GT 199800161A GT 199800161 A GT199800161 A GT 199800161A
Authority
GT
Guatemala
Prior art keywords
useful
indol
therapy
derived
sulfonilamino
Prior art date
Application number
GT199800161A
Other languages
English (en)
Inventor
Stephen Challenger
Kevin Neil Dack
Andrew Michael Derrick
Roger Peter Dickinson
David Ellis
Yousef Hajikarimian
Kim James
Kim James Rawson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of GT199800161A publication Critical patent/GT199800161A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA INVENCION PROPORCIONA EL ACIDO (S)(+)3{1(1,3BENZODIOXOL5IL)2[(2METOXI4METILFENIL)SULFONILAMINO]2OXOETIL}1METIL1HINDOL6CARBOXILICO, QUE ESTA EN GRAN PARTE LIBRE DE SU ENANTIOMERO (R)(), Y DERIVADOS FARMACEUTICAMENTE ACEPTABLES DEL MISMO. LOS COMPUESTOS SON UTILES EN EL TRATAMIENTO DE LA INSUFICIENCIA RENAL AGUDA INTER ALIA, REESTENOSIS E HIPERTENSION PULMONAR.
GT199800161A 1997-10-22 1998-10-19 Derivado de indol util en terapia. GT199800161A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9722287.1A GB9722287D0 (en) 1997-10-22 1997-10-22 Compounds useful in therapy

Publications (1)

Publication Number Publication Date
GT199800161A true GT199800161A (es) 2000-04-11

Family

ID=10820904

Family Applications (1)

Application Number Title Priority Date Filing Date
GT199800161A GT199800161A (es) 1997-10-22 1998-10-19 Derivado de indol util en terapia.

Country Status (17)

Country Link
US (1) US6211223B1 (es)
AP (1) AP899A (es)
AR (1) AR014922A1 (es)
AU (1) AU1150999A (es)
BG (1) BG104394A (es)
CA (1) CA2308478C (es)
CZ (1) CZ20001514A3 (es)
DZ (1) DZ2628A1 (es)
GB (1) GB9722287D0 (es)
GT (1) GT199800161A (es)
MA (1) MA26556A1 (es)
MY (1) MY117148A (es)
PA (1) PA8461001A1 (es)
TN (1) TNSN98190A1 (es)
TW (1) TW483893B (es)
WO (1) WO1999020623A1 (es)
ZA (1) ZA989574B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9722287D0 (en) 1997-10-22 1997-12-17 Pfizer Ltd Compounds useful in therapy
AR037097A1 (es) 2001-10-05 2004-10-20 Novartis Ag Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento
CN106631920B (zh) * 2016-11-17 2018-11-13 贵州大学 一种2-羟基-4-甲基苯磺酸的制备方法
CN114507162A (zh) * 2020-11-16 2022-05-17 尚科生物医药（上海）有限公司 一种制备2-氟-5-甲氧基苯磺酰氯的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE189217T1 (de) * 1993-03-19 2000-02-15 Merck & Co Inc Phenoxyphenylessigsäurederivate
GB9609641D0 (en) * 1996-05-09 1996-07-10 Pfizer Ltd Compounds useful in therapy
GB9722287D0 (en) 1997-10-22 1997-12-17 Pfizer Ltd Compounds useful in therapy

Also Published As

Publication number Publication date
GB9722287D0 (en) 1997-12-17
AU1150999A (en) 1999-05-10
TNSN98190A1 (fr) 2005-03-15
BG104394A (en) 2001-09-28
DZ2628A1 (fr) 2003-03-08
CA2308478A1 (en) 1999-04-29
MY117148A (en) 2004-05-31
CZ20001514A3 (cs) 2001-09-12
ZA989574B (en) 2000-04-25
MA26556A1 (fr) 2004-12-20
CA2308478C (en) 2004-12-07
AR014922A1 (es) 2001-04-11
US6211223B1 (en) 2001-04-03
PA8461001A1 (es) 2000-05-24
WO1999020623A1 (en) 1999-04-29
AP9801370A0 (en) 1998-12-31
AP899A (en) 2000-11-17
TW483893B (en) 2002-04-21

Similar Documents

Publication Publication Date Title
MX9800625A (es) Marcfortinas y paraherquamidas antiparasitarias.
EA199800667A1 (ru) Новые фенантридины
DE59814072D1 (de) Verwendung von Agonisten des zentralen Cannabinoid-Rezeptors CB1
TR200000782T2 (tr) Resorsinol türevleri.
BG103591A (en) Pesticide 1-arylpyrazols
DE59712625D1 (de) Flammwidrige, halogenfreie Mischung
TR200202323T2 (tr) Akut akciğer harabiyeti ve fibrozitinin alfavß6 antagonistleriyle tedavisi
DE69920222D1 (de) Kalziumphosphatbeschichtete vesikel
NL1010890C2 (nl) Stabilisatormengsel.
ATE435648T1 (de) Derivaten von nodulisporen säure
BG102696A (en) Antipsoriasic nail varnish
TR199801582T2 (xx) Bakteri �ld�r�c� ve mantar �ld�r�c� peptit.
GT199800161A (es) Derivado de indol util en terapia.
ID16871A (id) Penggandeng alat penyemprot tahan api
MX9307047A (es) Compuestos de quinazolinas y bencimidazoles substituidos.
ATE337516T1 (de) Chlorgaszuführungssystem von geringer leistung
DK70997A (da) Modulære systembyggesæt "gør det selv huse".
ES2094228T3 (es) Peptidos anticoagulantes.
AR014352A1 (es) Mezclas fungicidas y procedimiento para controlar hongos nocivos con dichas mezclas
TR200100159T2 (tr) Antitrombotik maddeler olarak bispiperidinler
AR015382A1 (es) Mezclas fungicidas y el procedimiento para controlar hongos nocivos con dichas mezclas
DK0931082T3 (da) Nodulisporinsyrederivater
ECSP982700A (es) Derivado de indol util en terapia
SE9602416D0 (sv) New forms of an organic salt of N'N-diacetylcystine
ES2162203T3 (es) Procedimiento de preparacion de 3-piperazinilbenzoisotiazoles.